CG Oncology
Bob Lapetina currently serves as VP of Financial Planning and Analysis at CG Oncology, a position held since May 2024. Prior to this role, Bob was VP of Finance and Corporate Controller at Immunome, Inc. from May 2021 to May 2024. Academically, Bob obtained a Master of Business Administration with a focus on Accounting and Finance from Saint Joseph's University between January 2004 and May 2005, and a Bachelor of Business Administration in Accounting from the Fox School of Business at Temple University from September 1993 to May 1997.
This person is not in any offices
CG Oncology
1 followers
CG Oncology is a clinical-stage biotechnology company focused on developing the next evolution of oncolytic immunotherapy for patients with advanced cancer.